412 related articles for article (PubMed ID: 37247693)
1. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.
Rivera Rodríguez R; Johnson JJ
Pharmacol Ther; 2023 Aug; 248():108456. PubMed ID: 37247693
[TBL] [Abstract][Full Text] [Related]
2. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
3. Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease.
Bhat MA; Usman I; Dhaneshwar S
Curr Rev Clin Exp Pharmacol; 2024; 19(3):234-249. PubMed ID: 37859409
[TBL] [Abstract][Full Text] [Related]
4. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
Clarke K; Chintanaboina J
Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
[TBL] [Abstract][Full Text] [Related]
5. An Update on Herbal Products for the Management of Inflammatory Bowel Disease.
Arya H; Dass R; Chopra B; Kriplani P; Deswal G; Singh Grewal A; Dhingra AK; Kumar S
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(1):1-9. PubMed ID: 37497699
[TBL] [Abstract][Full Text] [Related]
6. [Polyphenols in the treatment of inflammatory bowel diseases].
Chojnacka K; Laskowska J
Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
[TBL] [Abstract][Full Text] [Related]
7. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
9. TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis.
Solitano V; Jairath V; Ungaro F; Peyrin-Biroulet L; Danese S
Med; 2024 May; 5(5):386-400. PubMed ID: 38574740
[TBL] [Abstract][Full Text] [Related]
10. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
Alimohammadi N; Koosha F; Rafeian-Kopaei M
Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220
[TBL] [Abstract][Full Text] [Related]
11. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
12. Diet, Food, and Nutritional Exposures and Inflammatory Bowel Disease or Progression of Disease: an Umbrella Review.
Christensen C; Knudsen A; Arnesen EK; Hatlebakk JG; Sletten IS; Fadnes LT
Adv Nutr; 2024 May; 15(5):100219. PubMed ID: 38599319
[TBL] [Abstract][Full Text] [Related]
13. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
[TBL] [Abstract][Full Text] [Related]
14. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review.
Ribeiro D; Proenca C; Rocha S; Lima JLFC; Carvalho F; Fernandes E; Freitas M
Curr Med Chem; 2018; 25(28):3374-3412. PubMed ID: 29446723
[TBL] [Abstract][Full Text] [Related]
16. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
17.
Hou M; Leng Y; Shi Y; Tan Z; Min X
Am J Chin Med; 2023; 51(6):1501-1526. PubMed ID: 37530507
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
[TBL] [Abstract][Full Text] [Related]
19. Current scenario in inflammatory bowel disease: drug development prospects.
Chandel S; Prakash A; Medhi B
Pharmacol Rep; 2015 Apr; 67(2):224-9. PubMed ID: 25712643
[TBL] [Abstract][Full Text] [Related]
20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
